AU Patent

AU2019204689A1 — Solid dosage forms of palbociclib

Assigned to Pfizer Inc · Expires 2019-07-18 · 7y expired

What this patent protects

The present invention relates to solid dosage forms of palbociclib comprising a water soluble acid. The dosage forms described herein have desirable pharmacokinetic 5 characteristics.

USPTO Abstract

The present invention relates to solid dosage forms of palbociclib comprising a water soluble acid. The dosage forms described herein have desirable pharmacokinetic 5 characteristics.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019204689A1
Jurisdiction
AU
Classification
—
Expires
2019-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.